3I Medical Technologies Profile
Key Indicators
- Authorised Capital ₹ 4.60 Cr
as on 01-11-2024
- Paid Up Capital ₹ 4.51 Cr
as on 01-11-2024
- Company Age 4 Year, 25 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.20 Cr
as on 01-11-2024
- Revenue 6.07%
(FY 2023)
- Profit -660.91%
(FY 2023)
- Ebitda -370.62%
(FY 2023)
- Net Worth -308.40%
(FY 2023)
- Total Assets 84.37%
(FY 2023)
About 3I Medical Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.60 Cr and a paid-up capital of Rs 4.51 Cr.
The company currently has active open charges totaling ₹5.20 Cr.
Anil Jain and Sachin Jha serve as directors at the Company.
- CIN/LLPIN
U33110TN2020PTC139683
- Company No.
139683
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Nov 2020
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does 3I Medical Technologies Private Limited offer?
3I Medical Technologies Private Limited offers a wide range of products and services, including Diagnostic Medical Imaging Equipment, Medical Imaging Machine & Accessories.
Who are the key members and board of directors at 3I Medical Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Jain  | Director | 25-Nov-2020 | Current |
| Sachin Jha | Director | 02-Jan-2023 | Current |
Financial Performance and Corporate Structure Insights of 3I Medical Technologies.
3I Medical Technologies Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.07% increase. The company also saw a substantial fall in profitability, with a 660.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 308.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of 3I Medical Technologies?
In 2023, 3I Medical Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 May 2022 | ₹5.20 Cr | Open |
How Many Employees Work at 3I Medical Technologies?
3I Medical Technologies has a workforce of 23 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of 3I Medical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped 3I Medical Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
